Chaturvedi / Singh / Yadav

Erschienen: 20.11.2025

Nanotheranostics in Metabolic Syndrome

Transforming Diagnosis and Therapeutics

Springer Nature Singapore

ISBN 9789819537457

Standardpreis


ca. 160,49 €

lieferbar, ca. 10 Tage

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

auch verfügbar als eBook (PDF) für 160,49 €

Bibliografische Daten

Fachbuch

Buch. Hardcover

2025

6 s/w-Abbildungen, 33 Farbabbildungen.

Umfang: 506 S.

Format (B x L): 16 x 24.1 cm

Gewicht: 1045

Verlag: Springer Nature Singapore

ISBN: 9789819537457

Produktbeschreibung

This book explores the potential of nanotechnology in treating metabolic disorders, highlighting its potential to improve drug delivery, early disease detection, and precision therapeutics. Metabolic syndrome is a significant global health challenge, with a five-fld increase in the risk of developing type-2 diabetes and a two-fold heightened risk of cardiovascular diseases. Despite advancements in understanding the pathogenesis of metabolic syndrome, current therapeutic interventions have not achieved optimal efficacy. The integration of nanotechnology into biomedicine is seen as a promising avenue to address this issue.

Nanoparticles can be engineered to carry anti-inflammatory agents, providing targeted relief at inflammation sites, reducing inflammation and minimizing systemic side effects. Nanotechnology also enhances drug delivery systems by navigating biological barriers and reaching specific sites with precision. This not only improves the bioavailability of therapeutic agents but also minimizes off-target effects, enhancing overall treatment effectiveness.

Nanotechnology also plays a pivotal role in early disease detection and diagnosis through innovative nano-imaging techniques. These techniques enable the visualization of molecular and cellular events at unprecedented resolutions, facilitating the identification of metabolic syndrome markers and associated disorders at their incipient stages. As research progresses, the integration of nanotechnology has the potential to redefine metabolic syndrome management, offering hope for improved patient outcomes and a healthier global population.

The chapters cover metabolic syndromes, including insulin resistance, hypertension, dyslipidemia, type 2 diabetes, obesity, inflammation, and non-alcoholic fatty liver disease. It provides up-to-date literature on mechanistic understanding and therapeutic strategies. It is a valuable resource for UG/PG students, clinicians, academicians, scientists, researchers, and industrial specialists in advanced materials science, flexible electronics, nanoelectronics, energy, environmental, and biomedical sciences.

Autorinnen und Autoren

Produktsicherheit

Hersteller

Springer Nature Customer Service Center GmbH

Europaplatz 3
69115 Heidelberg, DE

ProductSafety@springernature.com

Topseller & Empfehlungen für Sie

Ihre zuletzt angesehenen Produkte

Rezensionen

Dieses Set enthält folgende Produkte:
    Auch in folgendem Set erhältlich:

    • Produktempfehlungen personalisieren

      Ihre Vorteile:

      • Empfehlungen basierend auf ihren Interessen
      • Zeitersparnis durch passende Vorschläge

      Mehr informationen zu , , und

      Die ersten personalisierten Empfehlungen erhalten Sie nach zwei bis drei Klicks.

      Sie können diese Zustimmung zu einem späteren Zeitpunkt unproblematisch über die Datenschutz-Einstellungen wieder zurückziehen.

      nach oben

      Ihre Daten werden geladen ...